Loading…
NEXGEL, Inc. is projected to decline to $0.4856 by 2027, a -6% move from its current price of $0.5143. NXGL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.49 | $0.5139 | $0.539 | -0.07% |
| Jul 13 | $0.4801 | $0.5136 | $0.5493 | -0.14% |
| Jul 14 | $0.4726 | $0.5132 | $0.5573 | -0.21% |
| Jul 15 | $0.4663 | $0.5128 | $0.5641 | -0.28% |
| Jul 16 | $0.4607 | $0.5125 | $0.5701 | -0.35% |
| Jul 17 | $0.4557 | $0.5121 | $0.5755 | -0.43% |
| Jul 18 | $0.4512 | $0.5118 | $0.5805 | -0.50% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4512 | $0.5118 | $0.5805 | -0.50% |
| Week 2 | $0.4261 | $0.5092 | $0.6085 | -0.99% |
| Week 3 | $0.4073 | $0.5067 | $0.6303 | -1.48% |
| Week 4 | $0.3919 | $0.5042 | $0.6487 | -1.97% |
| Week 5 | $0.3785 | $0.5017 | $0.6649 | -2.45% |
| Week 6 | $0.3666 | $0.4992 | $0.6797 | -2.94% |
| Week 7 | $0.3559 | $0.4967 | $0.6932 | -3.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NEXGEL, Inc. is a Healthcare company that manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
It operates through two segments: Nexgel and CG labs, and offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions.
NEXGEL develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. It also engages in the converting and packaging business and serves customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc.
and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
NXGL is a healthcare stock with a current price of $0.5108 and a market capitalization of $4.71M. It ranks 5334 by market cap.
The near-term price outlook for 2026 shows a min of $0.501, an average of $0.5108, and a max of $0.6617, with a Neutral sentiment. The 30-day price channel ranges from $0.366 to $0.7129, and the stock faces technical levels at support $0.501 and resistance $0.611.
In the longer horizon, the forecast shows gradual upside: 2030 average price $0.5039 (ROI -1.3%), 2031 average $0.5947 (ROI 16.4%), 2033 average $0.6242 (ROI 22.2%), 2040 average $0.6816 (ROI 33.4%), and 2050 average $1.47 (ROI 187.5%). Sentiment shifts from Neutral in early years to Bullish in later years, reflecting potential upside risk and reward over time.
A major floor 15.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.6% away) — a key level to hold.
The nearest ceiling, 18.8% above — a clean break opens room to run.
A major ceiling 123.6% above — clearing it would confirm fresh momentum.
Key NXGL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NXGL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.5266 | Sell | $0.5244 | Sell |
| MA 10 | $0.5307 | Sell | $0.532 | Sell |
| MA 20 | $0.5458 | Sell | $0.5428 | Sell |
| MA 50 | $0.5633 | Sell | $0.5928 | Sell |
| MA 100 | $0.6972 | Sell | $0.7791 | Sell |
| MA 200 | $1.31 | Sell | $1.19 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.65 | Neutral |
| Stoch RSI (14) | 27.66 | Neutral |
| CCI (20) | -72.17 | Neutral |
| Williams %R (14) | -84.55 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -7.33 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 15.45 | Buy |
| TRIX (15) | -0.29 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 50.21 | Neutral |
| Momentum (10) | 0.00 | Buy |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 0.51 | Buy |
| ADX (14) | 9.36 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is Bearish with RSI(14) at 40. The stock trades below the longer-term SMA, with a SMA50 of $0.5669 and a SMA200 of $1.33. Near-term support is at $0.501 and resistance at $0.611, framing a relatively tight range around the current price.
The 30-day range sits between $0.366 and $0.7129, indicating substantial short-term volatility within a narrow overall band around the current level. The current price hovers near the defined support level, which provides a potential near-term floor but upside resistance remains near $0.611.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.501 | $0.5143 | $0.6603 | 0% | Neutral | |
| $0.3599 | $0.4856 | $0.7065 | -6% | Neutral | |
| $0.3131 | $0.4455 | $0.6869 | -13% | Neutral | |
| $0.2502 | $0.3723 | $0.6004 | -28% | Bearish | |
| $0.3308 | $0.5126 | $0.8578 | 0% | Neutral | |
| $0.3746 | $0.6026 | $1.04 | +17% | Neutral | |
| $0.3372 | $0.5622 | $0.9995 | +9% | Neutral | |
| $0.3627 | $0.6257 | $1.14 | +22% | Bullish | |
| $0.3134 | $0.5587 | $1.04 | +9% | Neutral | |
| $0.2723 | $0.5014 | $0.9561 | -3% | Neutral | |
| $0.3252 | $0.6979 | $1.45 | +36% | Bullish | |
| $0.6652 | $1.48 | $3.40 | +187% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.501 | $0.5143 | $0.6139 | +0.00% |
| August 2026 | $0.3939 | $0.4745 | $0.5938 | -7.73% |
| September 2026 | $0.3952 | $0.4821 | $0.6145 | +1.58% |
| October 2026 | $0.4151 | $0.5118 | $0.6627 | +6.17% |
| November 2026 | $0.4079 | $0.5076 | $0.6658 | -0.82% |
| December 2026 | $0.3963 | $0.4974 | $0.6603 | -2.00% |
Click any year to see its month-by-month NXGL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NXGL price prediction for 2026 points to an average of $0.5143 (low $0.501, high $0.6603) — a potential gain of 0% on today's $0.5143. Price action looks broadly range-bound.
In 2027, NXGL is projected to trade between $0.3599 and $0.7065, averaging $0.4856 — a potential decline of -6% from today's $0.5143. That is -6% versus the projected 2026 average. A consolidation phase looks the most probable path here.
NEXGEL, Inc.'s 2028 outlook centres on $0.4455, within a $0.3131 to $0.6869 range. That is -8% versus the projected 2027 average. That marks a -13% change versus current levels. Price action looks broadly range-bound.
By 2029, NXGL could reach as high as $0.6004, with a base case around $0.3723 and support toward $0.2502 — roughly -28% from $0.5143. Expect choppier, lower action through this leg of the cycle.
Expect NXGL to range from $0.3308 to $0.8578 through 2030. The $0.5126 average target implies a 0% move from current prices. That is up +38% on the projected 2029 average. Price action looks broadly range-bound.
The NXGL price prediction for 2031 points to an average of $0.6026 (low $0.3746, high $1.04) — a potential gain of +17% on today's $0.5143. A consolidation phase looks the most probable path here.
In 2032, NXGL is projected to trade between $0.3372 and $0.9995, averaging $0.5622 — a potential gain of +9% from today's $0.5143. That is -7% versus the projected 2031 average. Price action looks broadly range-bound.
NEXGEL, Inc.'s 2033 outlook centres on $0.6257, within a $0.3627 to $1.14 range. That is up +11% on the projected 2032 average. That marks a +22% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, NXGL could reach as high as $1.04, with a base case around $0.5587 and support toward $0.3134 — roughly +9% from $0.5143. Price action looks broadly range-bound.
Expect NXGL to range from $0.2723 to $0.9561 through 2035. The $0.5014 average target implies a -3% move from current prices. That is -10% versus the projected 2034 average. A consolidation phase looks the most probable path here.
The NXGL price prediction for 2040 points to an average of $0.6979 (low $0.3252, high $1.45) — a potential gain of +36% on today's $0.5143. Momentum favours further upside here.
In 2050, NXGL is projected to trade between $0.6652 and $3.40, averaging $1.48 — a potential gain of +187% from today's $0.5143. That is up +112% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NXGL today (≈ 1,944.390434 NXGL) could be worth
$2,874.16
+$1,874.16 (+187%) by 2050 · US Dollar
Based on the average projected NXGL price of $1.48 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NXGLwould be worth at today's price.
$1,000 invested in NXGL on Jul 10, 2025 (≈ 366.300364 NXGL) would be worth
$188.39
-$811.61 (-81.2%) today · 0.19× · US Dollar
Based on a NXGL entry price of $2.73 vs. today's $0.5143.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.565 | $910.27 | -9.0% |
| 1 month ago | $0.566 | $908.66 | -9.1% |
| 3 months ago | $0.572 | $899.13 | -10.1% |
| 6 months ago | $1.69 | $304.32 | -69.6% |
| 1 year ago | $2.73 | $188.39 | -81.2% |
| All time (4.6y) ago | $3.52 | $146.11 | -85.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NXGL forecast.
Our base-case forecast reaches $1.00 around 2050.
Implied market cap at $1.00: $9.23M
The multi-year forecast shows a mixed path with an early dip and later upside courage. For 2026, the average price is $0.5108 with a 0% ROI and neutral sentiment, suggesting a close-to-flat near-term path. By 2027–2029, the avg prices are $0.4813, $0.4365, and $0.361 respectively, with negative ROIs of -5.8%, -14.6%, and -29.3% and Neutral to Bearish sentiment in those years.
From 2030 onward, the outlook turns modestly more favorable: 2030 avg $0.5039 (ROI -1.3%, Neutral), 2031 avg $0.5947 (ROI 16.4%, Neutral), and 2033 avg $0.6242 (ROI 22.2%, Bullish). The forecast continues to reflect upside momentum in 2040 (avg $0.6816, ROI 33.4%, Bullish) and extends to 2050 (avg $1.47, ROI 187.5%, Bullish).
In summary, the path shows limited gains in the early years, followed by meaningful upside in the 2030s and beyond, with substantial upside potential by 2050. Key risks include near-term downside in several years and variable sentiment across the forecast horizon.
Tap a question to reveal the answer.
The 2030 forecast shows min $0.3181, avg $0.5039, max $0.8595 with ROI -1.3% and sentiment Neutral.
Forecasts show mixed returns: negative ROIs in 2027 (-5.8%), 2028 (-14.6%), and 2029 (-29.3%), then positive ROIs in 2031 (16.4%), 2033 (22.2%), 2040 (33.4%), and 2050 (187.5%). These are estimates, not guarantees.
Yes. The max forecast includes $1.05 in 2031, $1.46 in 2040, and $3.38 in 2050.
For 2026, min $0.501, avg $0.5108, max $0.6617, indicating near-current levels in the near term.
Forecasts are year-by-year min/avg/max prices with ROI and sentiment. For example, 2026: avg $0.5108 with Neutral sentiment; later years show Neutral to Bullish sentiment and various ROI figures up to 187.5% in 2050.
NEXGEL, Inc. Community Discussion
0Share your NEXGEL, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.